TRENDS IN USE OF ORAL ANTITHROMBOTIC AGENTS IN PATIENTS WITH ATRIAL FIBRILLATION AND MYOCARDIAL INFARCTION

Atrial fibrillation (AF) in the setting of myocardial infarction (MI) requires treatment with combinations of oral anticoagulants and antiplatelets. However, a variety and combinations of antithrombotic drugs have been suggested for patients with AF and MI. We aimed to investigate temporal trends in